company background image
6609 logo

Shanghai HeartCare Medical Technology SEHK:6609 Stock Report

Last Price

HK$16.96

Market Cap

HK$646.9m

7D

-15.1%

1Y

-57.3%

Updated

15 Apr, 2024

Data

Company Financials +

Shanghai HeartCare Medical Technology Corporation Limited

SEHK:6609 Stock Report

Market Cap: HK$646.9m

6609 Stock Overview

Shanghai HeartCare Medical Technology Corporation Limited develops, manufacture, and sells neuro-interventional medical devices.

6609 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Shanghai HeartCare Medical Technology Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai HeartCare Medical Technology
Historical stock prices
Current Share PriceHK$16.96
52 Week HighHK$43.00
52 Week LowHK$15.64
Beta0.74
1 Month Change-16.86%
3 Month Change-30.35%
1 Year Change-57.28%
3 Year Changen/a
5 Year Changen/a
Change since IPO-86.85%

Recent News & Updates

We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Jan 23
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Recent updates

We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Jan 23
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Aug 30
Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Aug 09
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

May 07
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Nov 29
We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Shareholder Returns

6609HK Medical EquipmentHK Market
7D-15.1%0.4%0.9%
1Y-57.3%-54.0%-14.1%

Return vs Industry: 6609 underperformed the Hong Kong Medical Equipment industry which returned -54% over the past year.

Return vs Market: 6609 underperformed the Hong Kong Market which returned -14.1% over the past year.

Price Volatility

Is 6609's price volatile compared to industry and market?
6609 volatility
6609 Average Weekly Movement6.3%
Medical Equipment Industry Average Movement7.4%
Market Average Movement7.5%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.8%

Stable Share Price: 6609's share price has been volatile over the past 3 months.

Volatility Over Time: 6609's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016368Guohui Wangwww.heartcare.com.cn

Shanghai HeartCare Medical Technology Corporation Limited develops, manufacture, and sells neuro-interventional medical devices. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, flow diverter, and vascular access devices, as well as neurovascular stenosis treatment, hemorrhagic stroke treatment, and interventional access. Its products are used for the treatment and prevention of acute ischemic stroke, neurovascular stenosis, and hemorrhagic stroke.

Shanghai HeartCare Medical Technology Corporation Limited Fundamentals Summary

How do Shanghai HeartCare Medical Technology's earnings and revenue compare to its market cap?
6609 fundamental statistics
Market capHK$646.87m
Earnings (TTM)-HK$101.68m
Revenue (TTM)HK$251.29m

2.6x

P/S Ratio

-6.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6609 income statement (TTM)
RevenueCN¥232.34m
Cost of RevenueCN¥68.59m
Gross ProfitCN¥163.76m
Other ExpensesCN¥257.77m
Earnings-CN¥94.01m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.46
Gross Margin70.48%
Net Profit Margin-40.46%
Debt/Equity Ratio0%

How did 6609 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.